Mara Dinsmoor, MD, MPH

Department of Obstetrics and Gynecology
Division of Maternal Fetal Medicine
Clinical Professor
Director of Research

Contact Information
847.570.2860
847.570.2910 fax
mdinsmoor@northshore.org

 Education

  • Undergraduate: Dartmouth College, Hanover, NH (1978)
  • Medical School: Indiana University School of Medicine (1982)
  • Post Graduate: Masters in Public Health (2002)
  • Residency: Medical Center Hospital of Vermont (now known as Fletcher Allen Healthcare) (1986)
  • Fellowship: University of Texas Health Science Center – San Antonio, TX (1988)

Board Certification

  • Obstetrics and Gynecology (1989-present)
  • Maternal Fetal Medicine (1990-present)

Research Interests

 My primary research interest has been infectious disease in pregnancy.  I am also the Primary Investigator for the NorthShore site of the Northwestern University center of the NICHD-sponsored Maternal Fetal Medicine Unit Network.  This network performs multi-center studies of pregnant women and their newborns. 

Academic and Administrative Appointments

  • (2001-present)    Director of Research, Department of Obstetrics and Gynecology, NorthShore University HealthSystem, Evanston, IL
  • (2001-2006)     Research and Education Committee, NorthShore University HealthSystem
  • (2001-2010)    Institutional Review Board, NorthShore University HealthSystem
  • (2001- 2010)    Obstetric Practice Committee, NorthShore University HealthSyste
  • (2003-present)   Infection Control Committee, NorthShore University HealthSyste
  • (2004-2011)     Professional Liability and Risk Management Strategies Committee, NorthShore University HealthSystem
  • (2005-2010)    Vice Chairman, Institutional Review Board, NorthShore University HealthSystem
  • (2013-present)   Epic Optimization Committee – Outpatient, NorthShore University HealthSystem
  • (2013-present)    Risk Management Subcommittee – Quality Committee of NorthShore University HealthSystem

Career Summary

After completing my fellowship, I joined the faculty at the Medical College of Virginia (now Virginia Commonwealth University) where I worked for 12 years.  I became a tenured Associate Professor and was the Head of the Maternal Fetal Medicine Division.  My research interests while there were HIV in pregnancy and group B streptococcus.  In 2001, I returned to the Midwest and have been with NorthShore University HealthSystem since then, reaching the rank of Clinical Professor.  My primary research focus here at NorthShore has been the NICHD Maternal Fetal Medicine Unit Network studies.

Honors and Awards

  • (1981)    Alpha Omega Alpha
  • (1982)    American Medical Women's Association Certificate of Achievement
  • (1987)    Infectious Disease Society for Obstetrics & Gynecology/Stuart Pharmaceutical's Fellowship for Research in Antimicrobial Chemotherapy
  • (1991)    NFID-Burroughs Wellcome Young Investigator Award
  • (1992)    Humana Award - presented by The Society of Perinatal Obstetricians “in recognition of clinical research which has led to a significant advance in the care of women and babies during pregnancy”
  • (1994-1998, 2000-2010)    Citation in The Best Doctors in America, 2nd, 3rd, 5th-8th editions
  • (1996-1997)    Citation in The Best Doctors in America: Southeast Region
  • (2004-2005)    Citation in “Guide to America’s Top Obstetricians and Gynecologists”, 2nd edition, published by the Consumers’ Research Council of America

Professional Memberships/Affiliations/Activities

  • (1988-1989)    March of Dimes, Healthy Mothers/Healthy Babies Coalition, San Antonio, TX
  • (1988-present)    Disease Society for Obstetrics-Gynecology
    Nominating Committee (1993-1994)
    Membership Committee (1994-1998)
    Council Member (1995-1998)
    Secretary and Program Chairman (2004-2006)
  • (1990)    Central Virginia AIDS Services and Education: "Women and AIDS" Conference; Workshop on Reproductive Rights of HIV-Infected Women
  • (1990)    WWBT-TV Call 12: Access to Prenatal Care
  • (1990-1996)    Medical Board, The Dalkon Shield Claimants Trust
  • (1990-2000)    Richmond OB/GYN Society
  • (1991-1992)    Central Virginia Task Force on Women and HIV/AIDS, Treasurer
  • (1991-2000)    HIV Care Consortium for the Central Region of Virginia, Member
  • (1991-2013)    American Public Health Association
  • (1992)    Task Force on AIDS, Subcommittee on Counseling, Testing and Primary Care Services, Virginia General Assembly
  • (1992-present)    Society of Maternal-Fetal Medicine (formerly Society of Perinatal Obstetricians)
    Leader, Special Interest Group on Infectious Disease
    Judge, Poster Session
    Judge, Oral Session
    Member, Practice Committee
  • (1992-1998; 2000)    Board of Directors, Virginia League for Planned Parenthood
    Chairman, Medical Affiliates Committee (1995-1998)
    Resources Committee (1995-1996)
  • (1992-2000)    Richmond Academy of Medicine
  • (1992-2000)    Richmond AIDS Consortium
  • (1994-1995)    Technical Bulletin Committee - Obstetrics; American College of Obstetrics and Gynecologists
  • (1990-present)    American College of Obstetrics and Gynecology, Fellow
  • (1994-2000)    South Atlantic Association of Obstetricians and Gynecologists
  • (1994-2013)    American Society of Microbiology
  • (1994-present)    Association of Professors of Gynecology and Obstetrics
  • (1995-1996)    Regional Perinatal Coordinating Council, Co-Director
  • (1996)    Ad hoc Committee to develop a protocol for the detection, prevention, and treatment of GBS; Dept. of Health (for the Virginia General Assembly)
  • (1997-present)    American Board of Obstetrics and Gynecology
    Examiner-Obstetrics and Gynecology (1997-present)
    Examiner-Maternal-Fetal Medicine (2000)
  • (1998- 2000)    Panel member, Virginia Birth- Related Neurological Injury Compensation Program
  • (2000-present)    Member, Ware-Dunn Society, Richmond, VA
  • (2001-2013)    Member, Academy for Health Services Research and Health Policy
  • (2001-present)    Member, The Central Association of Obstetricians and Gynecologists

Scholarly Work

Publications:

  1. Dinsmoor MJ.  Group B Streptococcus.  Contemp Obstet Gynecol 1990; 35:93-104.
  2. Dinsmoor MJ.  HIV Infection and pregnancy.  Infectious Diseases Digest 1990;1:15.
  3. Dinsmoor MJ.  Common Vaginal Discharges: Matching the Symptoms with the Diagnosis.  Med Aspects Hum Sex, May, 1991.
  4. Dinsmoor MJ.  Obstetric and neonatal infection. Curr Op Obstet Gynecol 1991;3:707-714.
  5. Dinsmoor MJ and Dinsmoor RS.  All about yeast infections.  Diabetes Self-Management, pp 22-25, Nov/Dec, 1991.
  6. Dinsmoor MJ.  Ophthalmia neonatorum.  Contemp Obstet Gynecol 1992;37:112-114.
  7. Dinsmoor MJ, Grossman J. Perinatal viral and parasitic infections.  ACOG Technical Bulletin No. 177, February 1993.
  8. Dinsmoor, MJ.  Ophthalmia neonatorum.  Contemp Ob/Gyn 1998;43:25-28.
  9. Preventing GBS transmission to neonates.  Round-table Discussion with Drs. P. Mead, L. Gilstrap, J. Larsen.  Contemp Obstet Gynecol 1998; 43:53-69.
  10. Mead, PB, Dinsmoor, MF, Gibbs R.  Bacterial vaginosis in pregnancy (symposium).  Contemp Obstet Gynecol, 2000 45:37-51.
  11. Dinsmoor MJ.  Current Management of HIV in Pregnancy.   Contemp Obstet Gynecol 2000; 45:52-59.
  12. Dinsmoor MJ.  Hepatitis C in Pregnancy.  Current Women’s Health Reports.  2001;1:27-30.
  13. Dinsmoor MJ.  I love pus.  Contemp Obstet Gynecol 2004;49:104.
  14. Dinsmoor, MJ.  Are you up-to-date on the latest STI guidelines?  Contemp Obstet Gynecol 2007;52:102.
  15. Dinsmoor, MJ.  Should I get a flu shot while I’m pregnant?  Contemp Obstet Gynecol 2007;52:107-8.
  16. Dinsmoor MJ, Silverman NS, Soper DE.  Vaccines and Immune Therapy.  ACOG Update Tape Series.  Volume 26, July 2000-June 2001.
  17. Preconceptual Care—Infectious Disease. Website for Yourdoctor.com

Publications in Peer-Review Journals:

  1. Dinsmoor MJ and Gibson M. Early recognition of ectopic pregnancy in an infertility population.  Obstet Gynecol 68:859-8862, 1986.
  2. Gibbs RS, Dinsmoor MJ, Newton ER, Rammamurthy RS.  A randomized trial of intrapartum versus immediate postpartum treatment of women with intra-amniotic infection.  Obstet Gynecol 72:823, 1988.
  3. Dinsmoor MJ, Rammamurthy RS, Cassell GH, Gibbs RS.  Neonatal serologic response at term to the genital mycoplasmas.  Pediatr Infect Dis J  8:487-491, 1989.
  4. Newton ER, Dinsmoor MJ, Gibbs RS.  A randomized, blinded, placebo-controlled trial of antibiotics in idiopathic preterm labor.  Obstet Gynecol 74:562-566, 1989.
  5. Dinsmoor MJ, Gibbs RS.  Previous intra-amniotic infection as a risk factor for subsequent peripartal uterine infections.  Obstet Gynecol  74:299-301, 1989.
  6. Dinsmoor MJ, Rammamurthy RS, Gibbs RS.  Transmission of genital mycoplasmas from mother to neonate in women with prolonged membrane rupture.  Pediatr Infect Dis J  8:483-487, 1989.
  7. Dinsmoor MJ, Gibbs RS.  Prevalence of asymptomatic hepatitis B infection in pregnant Mexican-American women.  Obstet Gynecol 76:239-240, 1990.
  8. Dinsmoor MJ, Ebersole JE, Gibbs RS.  Protein banding patterns of the outer membrane-enriched fraction of Bacteroides bivius.  J Clin Micro 28:405-408, 1990.
  9. Dinsmoor MJ, Newton ER, Gibbs RS. A randomized, double-blind, placebo-controlled trial of oral antibiotic therapy following intravenous antibiotic therapy for postpartum endometritis.  Obstet Gynecol, 77:60-62, 1991.
  10. Dinsmoor MJ, Christmas JT.  Changes in T lymphocyte subpopulations during pregnancy complicated by human immunodeficiency virus infection.  Am J Obstet Gynecol, 167:1575-1579, 1992.
  11. Christmas JT, Knisely KS, Dawson KS, Dinsmoor MJ, Weber SE, Schnoll SH.  Comparison of questionnaire screening and urine toxicology for detection of pregnancy complicated by substance abuse.  Obstet Gynecol, 80:750-754, 1992.
  12. Dickason LA, Dinsmoor MJ. Red blood cell transfusion and cesarean section.  Am J Obstet Gynecol, 167:327-32, 1992.
  13. Dinsmoor MJ, Dalton H, Peng TCC, Christmas JT, Altaie S, Harvey K, VanDorsten JP.  A comparison of culture and rapid enzyme immunoassay for the detection of Group B streptococcus in high risk pregnancies. Infectious Diseases in Obstetrics and Gynecology, 2:115-119, 1994.
  14. Dinsmoor MJ, Irons SJ, Christmas JT.  Preterm rupture of the membranes associated with recent cocaine use.  Am J Obstet Gynecol, 171:305-309, 1994.
  15. Dinsmoor MJ, Hogg BA.  Autologous donation with placenta previa:  Is it feasible?  Am J Perinatol, 12:380-2, 1995.
  16. Jackson SL, O’Connell NG, Borzelleca JF, Dinsmoor MJ, Soper DE.  Cervicitis as a clinical indicator of gonococcal and chlamydial infections in pregnancy.  Infectious Diseases in Obstetrics and Gynecology 3:184-188, 1996.
  17. Schuchat A, Zywicki SS, Dinsmoor MJ, Mercer B, Romaguera J, O’Sullivan MJ, Patel D, Peters MT, Stoll B, Levine OS, and the Prevention of Early-onset Neonatal Sepsis (ENS) Study Group. Risk factors and opportunities for prevention of early-onset neonatal sepsis: A multicenter case-control study.  Pediatrics 105:21-6, 2000.
  18. Takacs P, Kauma SW, Sholley MM, Walsh SW, Dinsmoor MJ, Green K.  Increased circulating lipid peroxides in severe preeclampsia activate NF-6B and upregulate ICAM-1 in vascular endothelial cells. The FASEB Journal 15:279-281, 2001.
  19. Diaz LM, Lin P, Dinsmoor MJ.  Preventable risk factors for the delivery of very low birthweight infants in Richmond, Virginia.  Primary Care Update for OB/GYNs 8:1-4, 2001.
  20. Dinsmoor MJ and Seeds JW.  Fetal urethral obstruction with spontaneous rupture of the bladder and creation of gastroschisis.  Journal of Ultrasound in Medicine.  21:577-9, 2002.
  21. Dinsmoor MJ and Forrest ST.  The use of protease inhibitors in pregnancy does not increase the likelihood of an abnormal glucola test result.  Infectious Diseases in Ob/Gyn. 10:187-91, 2002.
  22. Dinsmoor MJ.  Prophylactic antibiotics in labor and delivery.  ACOG Practice Bulletin #47.  Obstet Gynecol  102:875-82, 2003.
  23. Dinsmoor MJ, Bachman R, Haney EI, Goldstein M, MacKendrick W.  Outcomes following expectant management of extremely preterm premature rupture of the membranes.  Am J Obstet Gynecol 190:183-7, 2004.
  24. Dinsmoor MJ and Brock EL.  Predicting failed trial of labor after cesarean delivery.  Obstet Gynecol 103:282-8, 2004.
  25. Dinsmoor, MJ.  Group B Streptococcus:  A culture-based prevention strategy.  The Female Patient. 29:24-30, 2004.
  26. Dinsmoor, MJ.  Should pregnant patients be worried about West Nile virus?  Contemp Obstet Gynecol  49:66-75, 2004.
  27. Sambaziotis H, Dinsmoor, MJ.  Diagnostic Puzzler: A simple UTI that wasn’t so simple.  Contemp Obstet Gynecol 50:89-92, 2005.
  28. Dinsmoor MJ, Viloria R, Lief L, Elder S.  The use of intrapartum antibiotics is associated with an increased incidence of postnatal maternal and neonatal yeast infections.  Obstet Gynecol; 2005;106:19-22.
  29. Parilla BV, Endres LK, Dinsmoor MJ, Curran L.  In utero progression of mild fetal ventriculomegaly.  Int J Obstet Gynecol; 2006;93:106-109.
  30. Maizels M, Wang E, Sabbagha R, Dinsmoor M, Seshadri R, Ginsberg N, Gauthier D, Abramowicz J.  Late 2nd trimester assessment of pyelectasis to predict pediatric urological outcome is improved by checking additional features.  J Mat Fet Neo Med 2006;19:295-303.
  31. Dinsmoor MJ, Gilbert S, Landon MB et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.  Perioperative antibiotic prophylaxis for nonlaboring cesarean delivery.  Obstet Gynecol 2009;114:752-6.
  32. Weiner LE, Dinsmoor MJ, Silver RK.   Severe hydramnios and preterm delivery in association with transient maternal diabetes insipidus.  Obstet Gynecol 2010; 116:547-549.
  33. Harper M, Zheng SL, Thom E, Klebanoff MA, Thorp J Jr, Sorokin Y, Varner MW, Iams JD, Dinsmoor M, Mercer BM, Rouse DJ, Ramin SM, Anderson GD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Cytokine gene polymorphisms and length of gestation. Obstet Gynecol 2011; 117:125-130.

 

Books:

  1. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam in mauris est.
  2. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam in mauris est.
  3. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam in mauris est.

Book Chapters:

  1. Dinsmoor MJ and Gibbs RS. The role of the newer antimicrobial agents in obstetrics and gynecology.  Clin Obstet Gynecol 31:423, 1988.
  2. Dinsmoor MJ.  HIV Infection and pregnancy.  Med Clin North Am 73:701-712, 1989.
  3. Dinsmoor MJ.  Pregnancy and Breast Cancer.  In:  The Female Breast and Its Disorders:  Essentials of Diagnosis and Management.  Mitchell GW and Bassett L (Eds.) Williams & Wilkins, 1990, 273-281.
  4. Dinsmoor MJ.  Imipenem-cilastatin.  Obstet Gynecol Clin North Am, 19:475-482, 1992.
  5. Dinsmoor MJ.  Ophthalmia neonatorum.  Infection Protocols for Obstetrics and Gynecology.  Montvale, NJ:  Medical Economics Publishing, 1992; revised 1997.
  6. Dinsmoor MJ.  HIV infection and pregnancy.  Clin Perinat 21:85-94, 1994.
  7. Dinsmoor MJ.  Group B Streptococcus.  In:  Current Therapy in Obstetrics and Gynecology, 4th Edition.  Quilligan EJ and Zuspan FP (Ed.), WB Saunders, 1994.
  8. Dinsmoor MJ.  Maternal Disease:  Group B Streptococcus.  In:  Management of High Risk Pregnancy.  Queenan, JT.  Hobbins JC, Spong CY, ed.  Malden, MA: Blackwell Publishing, 1994; revised 1997, 2005, 2009, 2014.
  9. Dinsmoor, MJ.  Hepatitis in the obstetric patient.  Inf  Dis Clin NA 11:77-91, 1997.
  10. Dinsmoor MJ and Gilstrap JE.  “Infection Control.”  In: Operative Obstetrics, 2nd edition.  Gilstrap et al, ed.  New York:  The McGraw-Hill Companies, 2002.

Peer Review Service:

  • (1988-present)  Reviewer
    American Journal of Obstetrics and Gynecology
    Obstetrics and Gynecology
    Antimicrobial Agents and Chemotherapy
    Journal of Reproductive Medicine
    International Journal of Obstetrics and Gynecology
    Infectious Diseases in Obstetrics and Gynecology
  • (1990)  Grant Reviewer, March of Dimes
  • (1992-1996)  Editorial Board, Infectious Diseases in Obstetrics and Gynecology
  • (1995)  Grant Reviewer, Thomas F. and Kate Miller Jeffress Memorial Trust
  • (1996)  Grant Reviewer, ACOG/Curatek Pharmaceuticals Research Award in Lower Genital Infections
  • (1998)  Chair, Selection Committee, ACOG/3M Pharmaceuticals Research Award in Lower Genital Infections
  • (2003- 2011)  Editorial Board, Contemporary Ob/Gyn
  • (2004-2006)  Infectious Disease Society for Obstetrics-Gynecology; Secretary and Program Chairman
  • (2007)  Reviewer, NICHD Concept Proposal
  • (2006-08)  Program Committee,  The Central Association of Obstetricians and Gynecologists

Presentations:

  1. Hard RC, Jr., Bagwell CE, Dinsmoor MJ, Draper DA, Ellis CR, Everett LL, Ferreiro-Gonzalez A, Garrett CT, Goehle D, Hart ME, Haynes JH, Lavoie S, Meloy LD, Morris RW, Shapiro JH, Singh MK, Smith T, Sonnino RE, Tipton GA.  Tests for HIV-1 and Zidovudine in Lymph Node Cells (LNC) from Newborns of Infected Mothers. 5th Conference on Retroviruses and Opportunistic Infections, 1998.
  2. Forrest ST, Lavoie SR, Dinsmoor M J.  “Highly-active anti-retroviral therapy” in pregnancy: Preliminary observations.  Annual meeting of the Infectious Disease Society for Obstetrics-Gynecology, Jackson Hole, WY, August 5-8, 1998.
  3. Diaz LM, Lin P, Dinsmoor MJ.  Preventable risk factors for delivery of very low birth weight infants in Richmond, Virginia.  Presented at the Annual meeting of District IV, American College of Obstetricians and Gynecologists.  White Sulphur Springs, WV, November 2, 1998.
  4. Fegley M, Al-Mateen B, Dinsmoor MJ.  Effect of labor and rupture of membranes on outcome of neonatal gastroschisis in mothers delivered by cesarean section.  Presented at the Annual meeting of District IV, American College of Obstetricians and Gynecologists, White Sulphur Springs, WV, October 31, 1998.
  5. Levine OS, Zywicki S, Dinsmoor M, et al.  Risk factors and opportunities for prevention of early-onset neonatal sepsis: A multicenter case-control study.  Presented at the Annual meeting of the Society for Pediatric Research, San Francisco, CA, May 1-4, 1999.
  6. Hannon-Bert E, Elder S, Weymouth L, Dinsmoor MJ.  Changes in microbial flora in early-onset neonatal sepsis.  Presented at the 47th  Annual Clinical Meeting of the American College of Obstetricians and Gynecologists, Philadelphia, May 16-19, 1999.
  7. Forrest ST and Dinsmoor MJ.  Use of protease inhibitors in pregnancy does not increase the risk of elevated glucola results.  Presented at the Annual meeting of the Infectious Disease Society for Obstetrics-Gynecology, Toronto, August 5-7, 1999.
  8. Dinsmoor MJ and Tran CL.  Lack of correlation between CD4 count and genitourinary tract infections in pregnant women infected with HIV.  Presented at the Annual meeting of the Infectious Disease Society for Obstetrics-Gynecology, Toronto, August 5-7, 1999.
  9. Diaz LM, Lin P, Dinsmoor MJ.  Preventable risk factors for delivery of very low birth weight infants in Richmond, Virginia.  Resident Research Award.  Ware-Dunn Society Annual Meeting, October 1999.
  10. Elder S, Coleman V, Brennan MM, Dinsmoor MJ.  Increasing duration of breast-feeding by establishing an outpatient lactation service at MCV Hospitals and Physicians of the VCU Health System.  Presented at the 10th Annual Art of Breastfeeding Conference, Chapel Hill, NC, November 6-8, 2000.
  11. Elder S, Coleman V, Brennan M,  Viloria R, Dinsmoor M.  Increasing  duration of breast-feeding by establishing an outpatient lactation service at MCV Hospitals and Physicians of the VCU Health System. Presented at the annual clinical conference and exposition of the National Perinatal Association, Charlotte NC, November 16-18, 2000.
  12. Isaacs C and Dinsmoor M.  Congenital CMV infection presenting as a molar pregnancy.  Presented at the Annual meeting of the Infectious Disease Society for Obstetrics-Gynecology, Quebec City, August 8-11, 2001.
  13. Dinsmoor M and Brock E.  Predicting failed trial of labor after previous cesarean section.  Presented at the 22nd Annual meeting of the Society for Maternal-Fetal Medicine, New Orleans, January 15-19, 2002.
  14. Dinsmoor, MJ and Newton ER.  Dangerous aerobic gram negative rods:  A complication of prophylactic antibiotics for preterm premature rupture of the membranes.  Presented at the Annual meeting of the Infectious Disease Society for Obstetrics-Gynecology, Banff, Alberta, Canada.  August 8-10, 2002.
  15. Dinsmoor MJ, Bachman R,  Haney E, MacKendrick W.  Outcomes following expectant management of pre-viable preterm premature rupture of the membranes.  Presented at the annual meeting of the Central Association for Obstetrics and Gynecology, Las Vegas, NV; October 27-30, 2002.
  16. Leeth EA ,MacGregor SN, Dinsmoor MJ, Parilla BV, Beaird JA, ,Rawal A, Salafsky IS. Fryns sydrome:  Genetic heterogeneity, developmental migration defect, or both?  Presented at the Annual Clinical Genetics Meeting/34th Annual March of Dimes Clinical Genetics Conference.  San Diego, CA.  March 13-16, 2003.
  17. Dinsmoor MJ, Sorensen M. Changes in vaginal birth after cesarean section rates (VBACR) in North Carolina (NC).  Presented at the 50th Annual Meeting of the Society for Gynecologic Investigation.  Washington, D.C. March 26-20, 2003.
  18. Dinsmoor MJ, Madsen KM, Goldstein M, Lim C. Misoprostol induction for pregnancy termination.  Presented at the 51st annual clinical meeting of the American College of Obstetricians and Gynecologists, New Orleans, April 26-30, 2003.
  19. Dinsmoor MJ,  Sorensen MV, Goldstein M. Changes in vaginal birth after cesarean section rates (VBACR) over time in North Carolina.  Presented at the 16th annual meeting of the Society for Pediatric and Perinatal Epidemiologic Research; Atlanta GA  June 10-11, 2003.
  20. Jelcz M, Dinsmoor MJ, Kaul K, O’Leary D.  Normal neonatal outcome following second trimester West Nile virus infection.  Presented at the Annual meeting of the Infectious Disease Society for Obstetrics-Gynecology; Hyannis, MA  August 7-9, 2003.
  21. Dinsmoor MJ, Haney EI, Sabini M.  Factors associated with the decision to have fetal autopsy performed.  Presented at the 51st  Annual Scientific Meeting of the Society for Gynecologic Investigation.  Houston, TX, March 25-27, 2004.
  22. Haney EI, Dinsmoor MJ, Sabini M.  Racial and ethnic differences in fetal deaths in northeastern Illinois:  A review of 100,000 births. Presented at the 51st  Annual Scientific Meeting of the Society for Gynecologic Investigation.  Houston, TX, March 25-27, 2004.
  23. Dinsmoor MJ, Viloria R, Elder S.  Intrapartum antibiotics and the risk of postnatal candidiasis:  A pilot study.  Presented at the Annual meeting of the Pediatric Academic Society.  San Francisco, CA, May 1-4, 2004.
  24. Dinsmoor MJ, Viloria R, Elder S.  Is receipt of intrapartum antibiotics associated with an increased risk of postnatal candidiasis?  Presented at the Annual Meeting of the Infectious Disease Society for Obstetrics-Gynecology; San Diego, CA  August 4-7, 2004.
  25. Benson, MD, Haney EI, Dinsmoor MJ.  Shaking rigors during labor.  Presented at the Annual meeting of District V, American College of Obstetricians and Gynecologists.  Salt Lake City, UT.  September 17-19, 2004.
  26. Alpert SA, Maizels M, Wang EY, Dinsmoor MJ, Gauthier DW, Seshadri R, Kaplan WE. Monitoring fetal renal polar length before 25 weeks gestation improves parental counseling for fetal pyelectasis.  Presented at the Annual Meeting of the American Academy of Pediatrics; San Francisco, CA,  October 9-13, 2004.
  27. Maizels M, Wang E, Sabbagha R, Dinsmoor MJ, Seshadri R, Gauthier D, Ginsberg N, Abramowicz J. Late 2nd trimester assessment of pyelectasis (SERP) to predict pediatric urological outcome is improved by checking additional features.  Presented at the Annual Meeting of the Society for Maternal Fetal Medicine; Reno, NV; February 9-12, 2005.
  28. Parilla BV, Endres LE, Dinsmoor MJ, Curran L. The in utero progression of mild ventriculomegaly.  The American Institute of Ultrasound in Medicine 50th Annual Meeting, Orlando Florida. June 20, 2005.
  29. Dinsmoor MJ,  Duke A, MacKendrick B, Garb M, Haney E.  Neonatal outcomes of twins and triplets: Are they different?  Presented at the Annual Meeting of the American College of  Obstetricians and Gynecologists, Washington DC, May 6-10, 2006.
  30. Dinsmoor MJ, Haney EI, Hirsch E, Peterson L.  Community-associated methicillin resistant staphylococcus aureus: Incidence in the obstetric population.  Presented at the Annual Meeting of the Infectious Disease Society for Obstetrics-Gynecology, Monterey, California; August 3-5, 2006.
  31. Dinsmoor MJ for the NICHD MFMU Network.  The MFMU Cesarean Registry:  Perioperative prophylactic antibiotics at time of non-laboring cesarean section.  Presented at the Annual Meeting of the Society for Gynecologic Investigation, Reno, NV; March 14-17, 2007.
  32. Dinsmoor MJ, Rouse DJ, Anderson BA, Saade G.   A proposed randomized controlled trial of maternal hyperimmune globulin to prevent fetal infection.  Presented at the Congenital Cytomegalovirus Conference, Atlanta GA; November 4-6, 2008.
  33. Dinsmoor MJ, Gordon E, Adams M, Shmerling A. Use of a computerized physician order entry (CPOE) system improves but does not perfect antenatal screening for Group B streptococcus (GBS).   Presented at the 76th Annual Meeting of the Central Association of Obstetricians and Gynecologists, Maui HI; October 25-28, 2009.
  34. Conyac T, Endres L, Adams M, Dinsmoor MJ.  Does a fetal abdominal circumference size of 5cm or more larger than head circumference predict a shoulder dystocia?  Presented at the 78th Annual meeting of the Central Association of Obstetricians and Gynecologists, Nassau, Bahamas; October 26-29, 2011.
  35. Gonzalez A, Doll J, Morgan G, Young L, Dinsmoor M, Crawford S, Plunkett B. Elevated neonatal leptin is associated with fetal hypertrophic cardiomyopathy but not cardiac dysfunction. Reprod Sciences 2014; 21: S045A.
  36. Gonzalez A, Doll J, Morgan G, Young L, Dinsmoor M, Crawford S, Plunkett B. Elevated neonatal leptin is associated with fetal hypertrophic cardiomyopathy but not cardiac dysfunction. Poster presentation at 61st Annual Meeting of SGI, Florence, Italy. Mar 2014.

Grants: (since 2001)

  • (2001-2002)  Bristol-Myers Squibb
    - A Randomized, Double-Blind, Multi-Center,  Comparative Phase III Study of Intravenous BMS-284756 Followed by Oral BMS-284756 versus Intravenous Ampicillin/Sulbactam Followed by Oral Amoxicillin/Clavulanate in the Treatment of Acute Pelvic Infections.
  • (2004-2006) NICHD #HD040512-03 - Maternal Fetal Medicine Unit Network Subcontract (with Northwestern University – PI Alan Peaceman) – capitated funding
    - A randomized clinical trial of antioxidants to prevent preeclampsia.
    - A randomized trial of 17 alpha-hydroxyprogesterone caproate for prevention of preterm birth in multifetal gestation.
    - A randomized trial of Omega-3 fatty acid supplementation to prevent preterm birth in pregnancies at high risk.
    - A randomized trial of treatment for mild gestational diabetes
  • (2006-2011)  NICHD  #HD040512-06- Maternal Fetal Medicine Unit Network  Site PI;  – (PI Alan Peaceman at Northwestern University)
    - A randomized clinical trial of antioxidants to prevent preeclampsia (Omega-3).
    - A randomized trial of treatment for mild gestational diabetes (GDM).
    - A randomized trial of thyroid replacement for mothers with subclinical hypothyroidism or hypothyroxinemia (TSH).
    - A randomized trial of 17 alpha-hydroxyprogesterone caproate for prevention of preterm birth in nulliparous women with a short cervix (SCAN).
    - An observational cohort study to evaluate measures of quality of obstetric care (APEX)
    - Translating research into practice in obstetrics (TRIO).
  • (2011-2016)  NICHD #HD040512-14  Maternal Fetal Medicine Unit Network Site PI; (PI Alan Peaceman at Northwestern University)
    - A randomized trial of fetal ECG ST segment and T wave analysis as an adjunct to electronic fetal heart rate monitoring (STAN).
    - Antenatal late preterm steroids (ALPS): A randomized placebo-controlled trial.
    - A randomized trial to prevent congenital CMV infection (CMV).
    - A randomized trial  (ARRIVE).
  • (2011-2013)  Ariosa Diagnostics: Non-invasive Examination of Trisomy (Site PI)
    - Multicenter study of aneuploidy screening comparing cell free fetal DNA to current first trimester screening.
× Alternate Text